Pulmonary haemodynamic effects resulting from the obstruction of mediastinal lymphatic flow in anaesthetized rabbits

Medical Science Research

Volumn 27, Issue 5, 1999, Pages 345-348

  Cui, Yingjie ^a,b,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Endothelial injury; Lymphoedema; Mediastinum; Pulmonary hypertension; Pulmonary oedema

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART LEFT ATRIUM PRESSURE; HEART RIGHT VENTRICLE PRESSURE; HISTOLOGY; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG FLUID; LUNG HEMODYNAMICS; LUNG PARENCHYMA; LYMPH FLOW; LYMPHEDEMA; MALE; MEDIASTINUM; NONHUMAN; OBSTRUCTION; PULMONARY HYPERTENSION; RABBIT; SYSTOLIC BLOOD PRESSURE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0033023946     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Uhley HN, Leeds SE, Sampson JJ, Friedman M. Role of pulmonary lymphatics in chronic pulmonary oedema. Ci re Res 1962; 11:966-970.
2. Rabin ER, Meyer EC. Cardiopulmonary effects of pulmonary venous hypertension with special reference to pulmonary lymphatic flow. Circ Res 1960; 8:324-335.
3. Warren ME Drinker CK. Flow of lymph from the lungs of the dog. Am J Physiol 1942; 136:207-211.
4. Drake R, Giesler M, Laine G, Gabel J, Hansen T. Effect of outflow pressure on lung lymph flow in unanaesthetized sheep. J Appl Physiol 1985; 58:70-76.
5. Onizuka M, Fletebo T, Nicolaysen G. Lymph flow pattern in the intact thoracic duct in sheep. J Physiol 1997; 503:223-234.
6. Ryan TJ. The lymphatics. In: McGee JO, Isaacson PG, Wright NA (editors): Oxford Textbook of Pathology, Vol. 2a. Oxford: Oxford University Press; 1992. pp. 923.
7. Ryan TJ. Disorders affecting the lymphatic system. In: Jarrett A (editor): The Physiology and Pathophysiology of the Skin. London: Academic Press; 1978. pp. 1781-2008.
8. Ryan TJ. Disorders affecting the lymphatic system. In: Jarrett A (editor): The Physiology and Pathophysiology of the Skin. London: Academic Press; 1978. pp. 1755-1780.
9. RyanTJ. Structure and function of lymphatics. J Invest Dermatol 1989; 93:18-24.
10. Rubin LJ. ACCP consensus statement. Primary pulmonary hypertension. Chest 1993; 104:236-250.
11. Voelkel NF, Tuder RM. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 1995; 8:2129-2138.
12. Cool CD, Kennedy D, Voelkel NF, Tudor RM. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Palhol 1997:28:434-442.
13. Montravers P, Chollet MS, Marmuse JP, Gougerot PMA, Desmonts JM. Lymphatic release of cytokines during lung injury complicating severe pancreatitis. Am J Respir Crit Care Med 1995; 152:1527-1533.
14. Dugernier T, Deby-Dupont G, Roeseler J, Reynaert MS. Respiratory complications in severe acute pancreatitis. Acta Gastroenterol Belg 1991; 54:225-232.
15. Weis M, von Scheid! W. Cardiac allograft vasculopathy: a review. Circulation 1997; 96:2069-2077.
16. Hunter DN, Morgan CJ, Yacoub M, Evans TW. Pulmonary endothelial permeability following lung transplantation. Chest 1992; 102:417-421.
17. Tomashefski JF Jr, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 1983; 112:112-126.